IRADIMED CORP (IRMD) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
IRMD currently has 12.8M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 0.93% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 01, 2026 |
10-Q filing | 12.8M shares outstanding |
13M | 0 |
| Nov 03, 2025 |
10-Q filing | 12.7M shares outstanding |
13M | 0 |
| Aug 01, 2025 |
10-Q filing | 12.7M shares outstanding |
13M | 0 |
| May 05, 2025 |
10-Q filing | 12.7M shares outstanding |
13M | 0 |
| Mar 06, 2025 |
10-K filing | 12.7M shares outstanding |
13M | 0 |
| Oct 31, 2024 |
10-Q filing | 12.7M shares outstanding |
13M | 0 |
| Aug 01, 2024 |
10-Q filing | 12.7M shares outstanding |
13M | 0 |
| May 06, 2024 |
S-3/A filing: Iradimed Corporation files an S-3/A to offer common stock with an aggregate maximum offering price of $75,000,000.00. |
13M | 0 |
| May 02, 2024 |
10-Q filing | 12.7M shares outstanding |
13M | 0 |
| Apr 03, 2024 |
S-3 filing: Iradimed Corporation files an S-3 registration statement for the potential issuance of common stock with an aggregate maximum offering price of $75,000,000. |
13M | 0 |
| Mar 01, 2024 |
10-K filing | 12.7M shares outstanding |
13M | 0 |
| Nov 03, 2023 |
10-Q filing | 12.6M shares outstanding |
13M | 0 |
| Aug 03, 2023 |
10-Q filing | 12.6M shares outstanding |
13M | 0 |
| May 04, 2023 |
10-Q filing | 12.6M shares outstanding |
13M | 0 |
| Mar 02, 2023 |
10-K filing | 12.6M shares outstanding |
13M | 0 |
| Nov 03, 2022 |
10-Q filing | 12.6M shares outstanding |
13M | 0 |
| Aug 05, 2022 |
10-Q filing | 12.6M shares outstanding |
13M | 0 |
| May 06, 2022 |
10-Q filing | 12.6M shares outstanding |
13M | 0 |
| Mar 04, 2022 |
10-K filing | 12.6M shares outstanding |
13M | 0 |
| Nov 05, 2021 |
10-Q filing | 12.3M shares outstanding |
12M | 0 |
| Aug 06, 2021 |
10-Q filing | 12.3M shares outstanding |
12M | 0 |
| May 07, 2021 |
10-Q filing | 12.3M shares outstanding |
12M | 0 |
| Mar 05, 2021 |
10-K filing | 12.4M shares outstanding |
12M | 0 |
| Nov 06, 2020 |
10-Q filing | 12.2M shares outstanding |
12M | 0 |
| Aug 20, 2020 |
S-3 filing: Iradimed Corporation files an S-3 to offer shares of common stock to the public with an aggregate offering price not to exceed $40,000,000. |
12M | 0 |
| Aug 06, 2020 |
10-Q filing | 12.1M shares outstanding |
12M | 0 |
| May 07, 2020 |
10-Q filing | 12.2M shares outstanding |
12M | 0 |
| Mar 06, 2020 |
10-K filing | 11.7M shares outstanding |
12M | 0 |